Physician profile
Eric Lawrence Thomas
NPI 1073584470
$149,084.32
in general payments reported to CMS, 2019-2025
10 companies · $43K in 2025
The $43K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18K · 2020: $12K · 2021: $153 · 2022: $3,837 · 2023: $102 · 2024: $71K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $108K · Food and Beverage: $5,199 · Travel and Lodging: $1,559 · Gift: $20.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $107,712.70 |
| Food and Beverage | $5,198.62 |
| Travel and Lodging | $1,558.54 |
| Gift | $20.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $147,105.19 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,346.63 | 2024 | Linx Reflux Management System |
| C. R. Bard, INC. & Subsidiaries | $209.33 | 2019 | |
| Davol INC. | $201.34 | 2019-2024 | Phasix Mesh |
| Medtronic, INC. | $68.65 | 2025 | Manoscan |
| Ethicon US, LLC | $53.36 | 2023-2025 | Surgicel Nu-Knit, Linx Reflux Management System, Ethicon |
| Musculoskeletal Transplant Foundation INC. | $33.42 | 2019 | |
| Tela Bio, INC. | $25.25 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $23.74 | 2023 | Durasorb Monofilament Mesh |
| Thd America, INC. | $17.41 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.